{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T19:57:21Z","timestamp":1791662241252,"version":"4.3.4"},"reference-count":50,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:00:00Z","timestamp":1697500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"SIMETAP Study","award":["05\/2010RS"],"award-info":[{"award-number":["05\/2010RS"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and objectives: Arterial hypertension (HTN) is the leading preventable cause of atherosclerotic cardiovascular diseases (ASCVD) and death from all causes. This study aimed to determine the prevalence rates of HTN diagnosed according to the threshold diagnostic criteria 130\/80 mmHg and 140\/90 mmHg, to compare blood pressure (BP) control, and to evaluate their associations with cardiovascular diseases and cardiometabolic and renal risk factors. Materials and Methods: This was a cross-sectional observational study conducted in primary care with a population-based random sample: 6588 people aged 18.0\u2013102.8 years. Crude and adjusted prevalence rates of HTN were calculated. BP control was compared in HTN patients with and without ASCVD or chronic kidney disease (CKD). Their associations with cardiovascular diseases and cardiometabolic and renal factors were assessed using bivariate and multivariate analysis. Results: Adjusted prevalence rates of HTN diagnosed according to 140\/90 and 130\/90 criteria were 30.9% (32.9% male; 29.7% female) and 54.9% (63.2% male; 49.3% female), respectively. BP &lt; 130\/80 mmHg was achieved in 60.5% of HTN patients without ASCVD or CKD according to 140\/90 criterion, and 65.5% according to 130\/80 criterion. This BP-control was achieved in 70% of HTN patients with ASCVD and 71% with CKD, according to both criteria. Coronary heart disease (CHD), heart failure, atrial fibrillation, stroke, diabetes, prediabetes, low glomerular filtration rate (eGFR), hyperuricemia, hypercholesterolemia, obesity, overweight, and increased waist-to-height ratio were independently associated with HTN according to both criteria. Conclusions: Almost a third of the adult population has HTN according to the 140\/90 criterion, and more than half according to the 130\/90 criterion, with a higher prevalence in men. The main clinical conditions associated with HTN were heart failure, diabetes, CHD, low eGFR, and obesity.<\/jats:p>","DOI":"10.3390\/medicina59101846","type":"journal-article","created":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T08:08:33Z","timestamp":1697530113000},"page":"1846","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Prevalence Rates of Arterial Hypertension According to the Threshold Criteria of 140\/90 or 130\/80 mmHg and Associated Cardiometabolic and Renal Factors: SIMETAP-HTN Study"],"prefix":"10.3390","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2985-6078","authenticated-orcid":false,"given":"Vicente","family":"Pallar\u00e9s-Carratal\u00e1","sequence":"first","affiliation":[{"name":"Health Surveillance Unit, Mutual Insurance Union, 12004 Castellon, Spain"},{"name":"Department of Medicine, Jaume I University, 12006 Castellon, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7902-5504","authenticated-orcid":false,"given":"Antonio","family":"Ruiz-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Lipids and Cardiovascular Prevention Unit, Pinto University Health Centre, Pinto, 28320 Madrid, Spain"},{"name":"Department of Medicine, European University of Madrid, Villaviciosa de Odon, 28670 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adalberto","family":"Serrano-Cumplido","sequence":"additional","affiliation":[{"name":"Family and Community Medicine, Getxo, 48993 Bizkaia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezequiel","family":"Arranz-Mart\u00ednez","sequence":"additional","affiliation":[{"name":"San Blas Health Centre, Parla, 28981 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Antonio","family":"Divis\u00f3n-Garrote","sequence":"additional","affiliation":[{"name":"Casas Ib\u00e1\u00f1ez Health Center, 02200 Albacete, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Moy\u00e1-Amengual","sequence":"additional","affiliation":[{"name":"Santa Catalina Health Centre, 07001 Palma, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5584-4735","authenticated-orcid":false,"given":"Carlos","family":"Escobar-Cervantes","sequence":"additional","affiliation":[{"name":"La Paz University Hospital, 28046 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6135-7685","authenticated-orcid":false,"given":"Vivencio","family":"Barrios","sequence":"additional","affiliation":[{"name":"Ramon y Cajal University Hospital, 28034 Madrid, Spain"},{"name":"Department of Medicine, Alcala University, 28801 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,10,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1161\/HYPERTENSIONAHA.121.18192","article-title":"Hypertension pharmacological treatment in adults: A World Health Organization guideline executive summary","volume":"79","author":"DiPette","year":"2022","journal-title":"Hypertension"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/S0140-6736(12)61766-8","article-title":"A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990\u20132010: A systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lim","year":"2012","journal-title":"Lancet"},{"key":"ref_3","unstructured":"GBD 2017 Risk Factor Collaborators (2018). Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990\u20132017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet, 392, 1923\u20131994."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S2213-8587(14)70102-0","article-title":"Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration. Cardiovascular Disease, Chronic Kidney Disease, and Diabetes Mortality Burden of Cardiometabolic Risk Factors from 1980 to 2010: A Comparative Risk Assessment","volume":"2","author":"Danaei","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.2016.19043","article-title":"Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990\u20132015","volume":"317","author":"Forouzanfar","year":"2017","journal-title":"JAMA"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/s41569-021-00559-8","article-title":"Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension","volume":"18","author":"Zhou","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.018912","article-title":"Global disparities of hypertension prevalence and control: A systematic analysis of population-based studies from 90 countries","volume":"134","author":"Mills","year":"2016","journal-title":"Circulation"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jama.2013.184182","article-title":"Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries","volume":"310","author":"Chow","year":"2013","journal-title":"JAMA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0140-6736(16)31919-5","article-title":"Worldwide trends in blood pressure from 1975 to 2015: A pooled analysis of 1479 population-based measurement studies with 19\u00b71 million participants","volume":"389","author":"Zhou","year":"2017","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","article-title":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: A pooled analysis of 1201 population-representative studies with 104 million participants","volume":"398","author":"Zhou","year":"2021","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1161\/CIRCULATIONAHA.110.005645","article-title":"Trends in mortality from all causes and cardiovascular disease among hypertensive and nonhypertensive adults in the united states","volume":"123","author":"Ford","year":"2011","journal-title":"Circulation"},{"key":"ref_12","first-page":"368","article-title":"Factors associated with cardiovascular risk and cardiovascular and renal disease in the IBERICAN study: Final results","volume":"46","author":"Caro","year":"2020","journal-title":"Semergen"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.hipert.2012.07.003","article-title":"Coste de la hipertensi\u00f3n arterial en Espa\u00f1a","volume":"29","author":"Saez","year":"2012","journal-title":"Hipertens. Riesgo Vasc."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/CIRCOUTCOMES.114.001191","article-title":"Trends in hypertension control among the older population of spain from 2000 to 2001 to 2008 to 2010: Role of frequency and intensity of drug treatment","volume":"8","author":"Banegas","year":"2015","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Prospective Studies Collaboration (2002). Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet, 360, 1903\u20131913.","DOI":"10.1016\/S0140-6736(02)11911-8"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Mancia(Chairperson), G., Kreutz(Co-Chair), R., Brunstr\u00f6m, M., Burnier, M., Grassi, G., Januszewicz, A., Muiesan, M.L., Tsioufis, K., Agabiti-Rosei, E., and Algharably, E.A.E. (J. Hypertens., 2023). 2023 ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension. Endorsed by the European Renal Association (ERA) and the International Society of Hypertension (ISH), J. Hypertens., ahead of print.","DOI":"10.1097\/HJH.0000000000003480"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the american college of cardiology\/american heart association task force on clinical practice guidelines","volume":"71","author":"Whelton","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_18","first-page":"251","article-title":"SEMERGEN Hypertension and Cardiovascular Disease Working Group. Positioning for the management of arterial hypertension in Primary Care from the critical analysis of the American (2017) and European (2018) guidelines. Spanish Society of Primary Care Physicians (SEMERGEN)","volume":"45","author":"Garrote","year":"2019","journal-title":"Semergen"},{"key":"ref_19","unstructured":"World Health Organization (2023, August 31). Global Action Plan for the prevention And Control of Noncommunicable Diseases 2013\u20132020. Available online: http:\/\/apps.who.int\/iris\/bitstream\/10665\/94384\/1\/9789241506236_eng.pdf?ua=1."},{"key":"ref_20","first-page":"197","article-title":"Population and methodology of the SIMETAP study: Prevalence of cardiovascular risk factors, cardiovascular diseases, and related metabolic diseases","volume":"30","author":"Calle","year":"2018","journal-title":"Clin. Investig. Arterioscler."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","article-title":"Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; World heart federation; International Atherosclerosis Society; and International Association for the Study of Obesity","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/eurheartj\/ehab892","article-title":"European Society of Cardiology: Cardiovascular disease statistics 2021","volume":"43","author":"Timmis","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1001\/jama.289.18.2363","article-title":"Hypertension Prevalence and Blood Pressure Levels in 6 European Countries, Canada, and the United States","volume":"289","author":"Cooper","year":"2003","journal-title":"JAMA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1161\/HYPERTENSIONAHA.111.189100","article-title":"Does Blood Pressure Inevitably Rise With Age? Longitudinal Evidence Among Forager-Horticulturalists","volume":"60","author":"Gurven","year":"2012","journal-title":"Hypertension"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"E93","DOI":"10.1161\/CIR.0000000000001123","article-title":"Heart Disease and Stroke Statistics\u20142023 Update: A Report From the American Heart Association","volume":"147","author":"Tsao","year":"2023","journal-title":"Circulation"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"100044","DOI":"10.1016\/j.ijchy.2020.100044","article-title":"Prevalence and control rates of hypertension in the USA: 2017\u20132018","volume":"6","author":"Chobufo","year":"2020","journal-title":"Int. J. Cardiol. Hypertens."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1161\/HYPERTENSIONAHA.112.193078","article-title":"Achievement of Cardiometabolic Goals in Aware Hypertensive Patients in Spain: A nationwide population-based study","volume":"60","author":"Banegas","year":"2012","journal-title":"Hypertension"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1157\/13126043","article-title":"Prevalencia, distribuci\u00f3n y variabilidad geogr\u00e1fica de los principales factores de riesgo cardiovascular en Espa\u00f1a. An\u00e1lisis agrupado de datos individuales de estudios epidemiol\u00f3gicos poblacionales: Estudio ERICE","volume":"61","author":"Gabriel","year":"2008","journal-title":"Rev. Esp. Cardiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.recesp.2010.11.005","article-title":"Cardiovascular risk factors in Spain in the first decade of the 21st Century, a pooled analysis with individual data from 11 population-based studies: The DARIOS study","volume":"64","author":"Grau","year":"2011","journal-title":"Rev. Esp. Cardiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.recesp.2015.11.036","article-title":"Prevalencia, diagn\u00f3stico, tratamiento y control de la hipertensi\u00f3n arterial en Espa\u00f1a. Resultados del estudio Di@bet.es","volume":"69","author":"Delgado","year":"2016","journal-title":"Rev. Espa\u00f1ola Cardiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1157\/13125354","article-title":"Prevalencia de la hipertensi\u00f3n arterial en la poblaci\u00f3n de Castilla y Le\u00f3n","volume":"22","author":"Alonso","year":"2008","journal-title":"Gac. Sanit."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.gaceta.2010.01.010","article-title":"Prevalencia de diabetes mellitus y factores de riesgo cardiovascular en la poblaci\u00f3n adulta de la Comunidad de Madrid: Estudio PREDIMERC","volume":"24","author":"Torras","year":"2010","journal-title":"Gac. Sanit."},{"key":"ref_33","unstructured":"Ministerio de Sanidad, Servicios Sociales e Igualdad (2023, August 31). La Salud de la Poblaci\u00f3n en Espa\u00f1a. Resultados de la Encuesta Europea de Salud en Espa\u00f1a EESE 2014. Madrid 2017, Available online: http:\/\/www.mscbs.gob.es\/estadEstudios\/estadisticas\/EncuestaEuropea\/Enc_Eur_Salud_en_Esp_2014.html."},{"key":"ref_34","unstructured":"Ministerio de Sanidad (2023, August 31). Sanidad en datos. Encuesta Nacional de Salud de Espa\u00f1a 2017, Available online: https:\/\/www.sanidad.gob.es\/estadEstudios\/estadisticas\/encuestaNacional\/encuesta2017.html."},{"key":"ref_35","unstructured":"Subdirecci\u00f3n General de Informaci\u00f3n Sanitaria (2023, August 31). Indicadores Cl\u00ednicos en Atenci\u00f3n Primaria 2016. BDCAP. Madrid: Ministerio de Sanidad, Consumo y Bienestar Social, Available online: http:\/\/www.mscbs.gob.es\/estadEstudios\/estadisticas\/estadisticas\/estMinisterio\/SIAP\/home.html."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/HJH.0000000000003072","article-title":"BMI and blood pressure control among United States adults with hypertension","volume":"40","author":"Foti","year":"2022","journal-title":"J. Hypertens."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/s41371-021-00619-z","article-title":"Cardiovascular mortality risk in young adults with isolated systolic hypertension: Findings from population-based MONICA\/KORA cohort study","volume":"36","author":"Atasoy","year":"2022","journal-title":"J. Hum. Hypertens."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(14)62070-5","article-title":"Blood pressure-lowering treatment based on cardiovascular risk: A meta-analysis of individual patient data","volume":"384","author":"Sundstrom","year":"2014","journal-title":"Lancet"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e002126","DOI":"10.1161\/JAHA.115.002126","article-title":"Identifying Individuals at Risk for Cardiovascular Events Across the Spectrum of Blood Pressure Levels","volume":"4","author":"Karmali","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s40292-023-00568-3","article-title":"Impact of 2021 ESC Guidelines for Cardiovascular Disease Prevention on Hypertensive Patients Risk: Secondary Analysis of Save Your Heart Study","volume":"30","author":"Giua","year":"2023","journal-title":"High Blood Press. Cardiovasc. Prev."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Divison-Garrote, J.A., Carbayo-Herencia, J.A., Simarro-Rueda, M., Molina-Escribano, F., Escobar-Cervantes, C., Artigao-Rodenas, L.M., Gil-Guill\u00e9n, V., and Banegas, J.R. (Hypertension, 2023). Prognosis of Systolic Pressure 130 to 139 According to Risk. A Prospective Cohort Study Between 1992 and 2019, Hypertension, ahead of print.","DOI":"10.1161\/HYPERTENSIONAHA.123.21732"},{"key":"ref_44","unstructured":"(2023, August 31). WHO Consultation on Obesity (1999: Geneva, Switzerland) & World Health Organization. (2000). Obesity: Preventing and Managing the Global Epidemic: Report of a WHO Consultation. WHO Technical Report Series; 894. Available online: https:\/\/apps.who.int\/iris\/handle\/10665\/42330."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1177\/1054773817740533","article-title":"Predictive capacity and cutoff value of waist-to-height ratio in the incidence of metabolic syndrome","volume":"28","year":"2019","journal-title":"Clin. Nurs. Res"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.2337\/dc23-S002","article-title":"2. Classification and diagnosis of diabetes: Standards of care in diabetes\u20142023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann. Intern Med."},{"key":"ref_48","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2013). KDIGO 2012 Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. Suppl., 3, 5\u201314."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","article-title":"2016 European Guidelines on cardiovascular disease prevention in clinical practice. The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1177\/2047487315588390","article-title":"Cardiovascular disease risk estimation in older persons: SCORE O.P","volume":"23","author":"Cooney","year":"2016","journal-title":"Eur. J. Prev. Cardiol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/59\/10\/1846\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:08:28Z","timestamp":1760130508000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/59\/10\/1846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,17]]},"references-count":50,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["medicina59101846"],"URL":"https:\/\/doi.org\/10.3390\/medicina59101846","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,17]]}}}